Spire Healthcare Group (SPI) Raised to “Buy” at Berenberg Bank
Spire Healthcare Group (LON:SPI) was upgraded by equities research analysts at Berenberg Bank to a “buy” rating in a note issued to investors on Wednesday, November 29th, MarketBeat.com reports. The brokerage currently has a GBX 310 ($4.14) target price on the stock, up from their prior target price of GBX 270 ($3.61). Berenberg Bank’s target price would suggest a potential upside of 22.24% from the stock’s current price.
Other research analysts have also issued reports about the company. Numis Securities reiterated an “add” rating and issued a GBX 341 ($4.56) target price on shares of Spire Healthcare Group in a report on Monday, October 23rd. Liberum Capital reiterated a “hold” rating and issued a GBX 270 ($3.61) target price on shares of Spire Healthcare Group in a report on Thursday, November 16th. Jefferies Group decreased their target price on Spire Healthcare Group from GBX 350 ($4.68) to GBX 259 ($3.46) and set a “hold” rating for the company in a report on Monday, September 25th. Finally, JPMorgan Chase & Co. decreased their target price on Spire Healthcare Group from GBX 376 ($5.03) to GBX 339 ($4.53) and set a “neutral” rating for the company in a report on Friday, September 15th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. Spire Healthcare Group presently has an average rating of “Hold” and a consensus target price of GBX 309.86 ($4.14).
Spire Healthcare Group (LON:SPI) traded up GBX 3.40 ($0.05) during trading hours on Wednesday, reaching GBX 253.60 ($3.39). The company had a trading volume of 413,419 shares, compared to its average volume of 2,210,000. The stock has a market capitalization of $1,020.00 and a price-to-earnings ratio of 3,622.86. Spire Healthcare Group has a 52-week low of GBX 218.20 ($2.92) and a 52-week high of GBX 362.10 ($4.84).
Spire Healthcare Group Company Profile
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.